In a report released today, Alex Fuhrman from Craig-Hallum assigned a Buy rating to LifeVantage (LFVN – Research Report). The company’s shares ...

The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients ...

Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...

LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...

The company adopted its current name in November 2006. Initially focused on selling a single product, Protandim, through traditional retail stores from 2005 to 2009, LifeVantage transitioned to a ...

Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.

Preliminary Second Quarter Fiscal 2025 Highlights: Revenue of approximately $67.5 million, an increase of 31% from the prior year period, and up 43% sequentially from the first fiscal quarter ...

Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.

The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including its Protandim® product ...